Treatment Across the Prostate Cancer Continuum: Current Practice and Future Directions

The goal of this educational activity is to improve the knowledge and competence of oncologists in caring for a patient with prostate cancer across the staging spectrum through case-based discussions.
 
Educational Partner: Medscape, LLC
 
Medium: Online Presentation
 
Commercial Support: Supported by an independent educational grant from Astellas.
 
Developed through a collaboration between the University of Chicago Medicine and Medscape Education.

Target Audience

This activity is intended for hematology/oncology specialists, urologists, and pathologists.

Learning Objectives

Upon completion of this activity, participants will:
 
  • Have increased knowledge regarding the
    • Latest clinical data on therapies, including oral anti-androgens, across the prostate cancer continuum
  • Have greater competence related to
    • Identifying candidates for select therapies in prostate cancer reflective of disease-specific factors
    • Mitigating adverse events (AEs) associated with oral anti-androgen therapies
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Name: 
Medscape
CME Coordinator Contact Email: 
CME@medscape.net
Summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Participation
Activity opens: 
01/19/2021
Activity expires: 
01/19/2022
FACULTY
Karim Fizazi, MD, PhD
Professor of Oncology
Institut Gustave Roussy
University of Paris-Saclay
Villejuif, France
 
Celestia Higano, MD
Adjunct Professor
Department of Urologic Sciences
University of British Columbia
Medical Director
Prostate Cancer Supportive Care Program
Vancouver Prostate Centre
Vancouver, British Columbia, Canada
 
Akash Patnaik, MD
Assistant Professor of Medicine
UChicago Medicine
Chicago, Illinois, United States
 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Physician credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians
 
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Registration: To view this activity, you will need to visit Medscape's website.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!
 
Please login or create an account to proceed.